在固体瘤中增强CAR-T细胞透的障碍和策略:系统性审查

Yan Zhang1, Huihui Sun2, Lianfeng Zhao1

  • 1Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, China.

Immunology
|January 19, 2026
PubMed
概括

化学抗原受体T (CAR-T) 细胞疗法对固体瘤有希望,但面临透障碍. 本综述详细介绍了这些挑战,并探讨了提高对固体瘤的CAR-T细胞治疗疗效的策略.

相关概念视频